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Abstract
Cigarette smoking, high alcohol intake, and low dietary folate levels are risk factors for colorectal adenomas. Oxidative
damage caused by these three factors can be repaired through the base excision repair pathway (BER). We hypothesized
that genetic variation in BER might modify colorectal adenoma risk. In a sigmoidoscopy-based study, we examined
associations between 182 haplotype tagging SNPs in 14 BER genes, and colorectal adenoma risk, and examined their
potential role as modifiers of the effect cigarette smoking, alcohol intake, and dietary folate levels. Among all individuals, no
statistically significant associations between BER SNPs and adenoma risk persisted after correction for multiple comparisons.
However, among Asian-Pacific Islanders we observed two SNPs in FEN1 and one in NTHL1, and among African-Americans
one SNP in APEX1 that were associated with colorectal adenoma risk. Significant associations were also observed between
SNPs in the NEIL2 gene and rectal adenoma risk. Three SNPS modified the effect of smoking (MUTYH interaction p= 0.002;
OGG1 interaction p= 0.013); FEN1 interaction p= 0.013)), one SNP in LIG3 modified the effect of alcohol consumption
(interaction p= 0.024) and two SNPs in LIG3 modified the effect of dietary folate (interaction p= 0.001 and p= 0.08) on
colorectal adenoma risk. These findings support a role for genetic variants in the BER pathway as potential modifiers of
colorectal adenoma risk. Our findings strengthen the role of oxidative damage induced by key lifestyle and dietary risk
factors in colorectal adenoma formation.
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Introduction
Colorectal cancer (CRC) is the third most common cancer
diagnosed in men and women and is the third leading cause of
cancer death in the United States [1]. In 2011, there were
approximately 141,210 individuals diagnosed with CRC and
49,380 deaths from this disease in the United States [1]. More
than 80% of CRC evolve from neoplastic adenomatous polyps or
adenomas [2]. Prevalence of adenomas is estimated at 30% at age
50 and 40% by age 60 [3]. Compared to small (,1 cm) adenomas,
larger ones ($ 1 cm) have a greater potential to grow and progress
into CRC [4]. Use of endoscopy screening with polyp removal has
significantly reduced CRC incidence and mortality [5,6],
reinforcing the pathogenetic relationship between adenomas and
CRC. Therefore, the identification of risk factors for adenoma
development has significant public health implications.
Cigarette smoking [7,8] and folate deficiency [9] are established
adenoma risk factors, whereas folate supplementation may
promote progression of established adenomas [10]. Cigarette
smoke contains reactive oxygen species (ROS) and chemical
carcinogens [11] which can damage DNA [11,12]. Additionally,
smoking has been associated with decreased folate levels [13],
which may contribute to folate deficiency, which is associated with
double strand breaks and abasic sites [14].
Alcohol consumption is currently considered a convincing CRC
risk factor [15,16]. Increasing alcohol intake has previously been
shown to reduce folate levels [17,18]. Alcohol metabolism
generates acetaldehyde, a known mutagen which generate ROS
in the colon lumen [19,20], directly inhibits O6 methylguanine-
methyl-transferase, an enzyme involved in removal of alkylation-
induced DNA damage, and leads to hyper regeneration of crypt
cells which induces multiple forms of DNA damage [19,21]. In
addition, alcohol metabolism can induce cytochrome P450
enzymes, which can increase activation of chemical pro-carcino-
gens [19,22,23].
Overall, smoking, alcohol consumption and decreased folate
availability can lead to oxidative DNA damage and excess uracil
misincorporation, which may all contribute to adenoma develop-
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ment. The base excision repair (BER) pathway, is the predominant
mechanism for repair of oxidative DNA damage [24]. We
hypothesized that genetic variation in BER genes may modify
the risk of colorectal adenomas, in particular, in combination with
smoking, alcohol, and low dietary folate. We examined potential
associations between single nucleotide polymorphisms (SNPs) in
genes involved in BER and distal adenoma risk, and considered
their role as potential modifiers of the effect of cigarette smoking,
alcohol consumption, and dietary folate intake. Using data and
samples from a sigmoidoscopy-based study conducted in Los
Angeles County we comprehensively investigated associations
between genetic variation in 14 BER genes and colorectal
adenoma risk.
Methods
Ethics Statement
The research protocol was approved by the institutional review
boards at both USC and Kaiser Permanente, and all subjects
signed a written informed consent approved by both institutions.
Study Subjects
Study participants were enrolled in a University of Southern
California/Kaiser Permanente study of risk factors for colorectal
adenomas. All individuals were examined by flexible sigmoidos-
copy from 1991 to 1993 (phase I) and from 1993 to 1995 (phase II)
at one of two southern California Kaiser Permanente clinics
(Bellflower or Sunset), and were recruited using identical criteria,
as we have previously described [25,26]. Briefly, cases were
individuals with a first-time diagnosis of a histologically confirmed
adenoma. Controls were selected from the remaining eligible
individuals who did not present with polyps at sigmoidoscopy
examination and had no past history of histologically confirmed
adenomas. Controls were individually matched to cases by gender,
age (within 5 years), sigmoidoscopy date (within 3 months), and
Kaiser Permanente clinic. All subjects signed a written informed
consent approved by the Institutional Review Board, donated a
blood sample, and completed two questionnaires. A risk factor
questionnaire was administered during an in-person interview, and
collected data on demographics, smoking history, family history of
cancer, physical activity and other factors described previously
[27,28]. A semi-quantitative food frequency questionnaire was
administered in reference to diet during the year before
sigmoidoscopy examination, as previously described [29].
SNP Selection and Genotyping
TagSNPs for each BER gene were selected using Haploview
Tagger [30] based on the HapMap CEPH (CEU) population
using the following criteria: minor allele frequency (MAF) $5%,
pairwise r2$0.95, and a distance from the closest SNP greater
than 60 base pairs on the Illumina platform. Linkage disequilib-
rium (LD) blocks were defined using data from HapMap data
release #16c.1, June 2005, on NCBI B34 assembly, dbSNP b124.
For each gene, we included the 59- and 39-most SNP within the
LD block within ,10 kb upstream and ,5 kb downstream. In
regions of no or low LD, tagSNPs with a MAF $5% at a density
of , 1 per kb were selected from either HapMap or dbSNP. In
this analysis, we report our results for 182 tagSNPs across 14 genes
that participate in the BER pathway (Table 1 and Table S1).
TagSNPs were genotyped on the Illumina GoldenGate platform,
as we previously described [31]. Among the BER genes in our
study, we required that all 182 tagSNPs have call rates $0.90 and
that we not observe evidence of statistically significant deviations
of observed from expected values, when assuming Hardy-
Weinberg equilibrium $0.00027 using exact tests (Bonferroni-
corrected p value; a=0.05/182). All tagSNPs met these two
requirements. Additionally, we required all individuals had overall
call rates $90%, which led to exclusion from analyses of 89
individuals. We included in final analyses genotype data from
1,368 (94%; 677 cases and 691 controls) of 1,457 total subjects in
this study. Demographic and matching characteristics for individ-
uals with and without genotype data were not statistically
significantly different.
Statistical Analysis
SNP main effect analyses. Deviations of observed genotype
frequencies from those expected when assuming HWE were
examined among controls by race/ethnicity using exact tests. We
used unconditional logistic regression, assuming a log-additive
model, to estimate per-allele odds ratios (ORs) and corresponding
95% confidence intervals (95% CIs) for the association between
genotype and adenoma risk, adjusting for race (Non-Hispanic
Whites, Latinos, African-American, Asian/Pacific Islander), study
phase (phase I/phase II), age at sigmoidoscopy (continuous),
gender, exam date, and clinic (Bellflower or Sunset). In this study,
similar results are obtained when using unconditional logistic
regression adjusting for the matching factors as using conditional
logistic regression, with the benefit of using all genotype
information in the study population [26]. Additional control for
the following adenoma risk factors did not change ORs by more
than 10%; therefore, they were not included in final analyses:
alcohol intake (g/day), smoking status, dietary folate intake (mcg/
day), body mass index, multivitamin use (yes/no), total caloric
intake, total dietary fiber (g/day).
When testing SNP main effects we corrected for multiple testing
within each gene region as well as across all BER gene regions
investigated. Specifically, for each tagSNP obtained under a log-
additive model, p-values were corrected for multiple testing, taking
into account multiple correlated tests due to LD between SNPs
within each gene region, using the PACT (p-value adjusted for
correlated tests) method implemented in the PACT R package [32].
Additionally, we corrected for multiple testing between gene
regions by applying a Bonferroni correction multiplying each
PACT p-value by the 14 investigated BER gene regions to
determine overall pathway significance (ppathway) [33]. We assessed
potential heterogeneity of SNP main effects by race/ethnicity
(among tagSNPs with MAF .5% in controls for each race/
ethnicity), by performing 3df likelihood-ratio tests of interaction
between genotypes and race/ethnicity. We used multinomial
logistic regression to examine differences in SNP main effects by
adenoma location (rectal versus left colon) and adenoma size
(,1 cm) versus $1 cm) with respect to the control group. SNP
main effect p-values for stratified analyses were corrected using
PACT as described above. When considering linkage between
different SNPs we used the square of the correlation coefficient
(R2) to estimate pairwise LD using Haploview [30].
TagSNP 6 environmental risk factor interactions. We
investigated whether BER genes tagSNPs modify the effect of
alcohol use, dietary folate intake, or smoking in all individuals and
in non-Hispanic Whites (NHW) only. We categorized smoking
variables using median values among smoking controls to create
the following variables: smoking status (never, quit, current), years
of smoking (0, #26 years, .26 years), pack-years smoked (0, #21
pack years, .21 pack years). We also considered the following
alcohol intake variables: number of drinks per day (never, #1
drink/day, .1 drink/day) and median daily alcohol intake (using
median intake among drinking controls as a cut point: 0, #6 g/d,
.6 g/d), with one alcoholic drink per day defined as approxi-
BER Pathway and Colorectal Adenoma Risk
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mately 15 grams of ethanol. We considered a dietary folate intake
variable (low/medium/high) defined using tertiles of dietary folate
intake among controls as cut points: #267 mcg/day, .267–
387 mcg/day, $388 mcg/day).
Analyses of gene-environment interactions (GxE) were con-
ducted by testing interaction terms between tagSNPs (assuming a
log-additive model) and each environmental exposure using
likelihood ratio tests based on unconditional logistic regression.
To reduce the multiple testing burden and avoid possible failure of
asymptotic tests, any tagSNPs for which a genotypic category
count was less than 10 for any of the environmental factor strata
considered was not included in analyses. Gene-exposure interac-
tions were mutually adjusted for all three exposures considered.
Further adjustment for body mass index, multivitamin use (yes/
no), total caloric intake, or total dietary fiber (g/day) produced
almost identical estimates; therefore we did not keep these
variables in the models.
We corrected for multiple testing by applying two Bonferroni
corrections to the crude interaction p-values which we report
separately: first, we applied a within gene region Bonferroni
correction (interaction pgene), by considering the number of
tagSNPs in its respective gene region; second, we applied an
overall pathway Bonferroni correction (interaction ppathway), by
considering the 14 investigated BER gene regions. Statistical
significance was declared if either corrected p-values were ,0.05.
All tests conducted were two sided and all statistical analysis were
conducted using Stata 11 SE (Stata Corporation, College Station,
TX) and the R programming language (The R Project for
Statistical Computing, http://www.r-project.org).
Results
Demographic characteristics of all cases (N= 721) and controls
(N= 736) in our study are summarized in Table 2. As we
previously described [25], there were no differences in age, gender,
ethnicity, alcohol intake and smoking patterns between Phase I
and Phase II participants. However, Phase II participants had
higher dietary folate intake than those who participated in phase I
(p =,0.001). Fifty-two percent of enrolled subjects were NHW.
The mean age of cases was 61.46 years (66.75) and the mean age
of controls was 61.67 years (66.88). Cases smoked longer and
more intensely than controls and were more likely to be current
smokers (p,0.001). Cases were also found to have a lower mean
dietary folate intake (mcg/d) and a lower mean dietary fiber intake
(g/d) than controls (p = 0.013; p = 0.036). Approximately 81% of
adenomas were colon adenomas and approximately 67% were
small adenomas (,1 cm).
BER Genes and Colorectal Adenoma Risk
Among all individuals combined, out of the 182 tagSNPs only
NEIL2 rs11785481 showed a statistically significant association
with adenoma risk; however, it was not statistically significant after
multiple comparisons adjustment within gene region (PACT)
(OR=0.70; 95%CI= 0.55–0.90; p= 0.006; PACT= 0.140)
(Table 3).
When considering stratified analyses by racial/ethnic group,
among African-Americans we observed an association with APEX1
rs17111750 (OR=2.19; 95%CI= 1.36–3.55; PACT=0.013;
ppathway = 0.180; pheterogeneity = 0.004)(Table 3). Among Asian-
Pacific Islanders we observed an association with two tagSNPs
in the FEN1 gene, rs108499 (OR=2.12; 95%CI= 1.30–3.45;
PACT= 0.009; ppathway = 0.129; pheterogeneity = 0.024) and rs509360
(OR=0.40; 95%CI= 0.30–0.79; PACT= 0.011; ppathway = 0.159;
pheterogeneity = 0.052), and one tagSNP in NTHL1, rs2516781
(OR=0.45; 95%CI= 0.25–0.80; PACT= 0.032; ppathway = 0.461;
pheterogeneity = 0.062)(Table 3). All estimates of per-allele associa-
tions for adenoma risk among all individuals combined and by
race/ethnicity are shown in Table S2.
Table 1. Base excision repair pathway genes investigated.
Gene Symbol # tagSNPs Chromosomal location Protein Function
APEX1 13 14q11.2 Endonuclease
FEN1 7 11q12 Endonuclease
LIG1 23 19q13.2-q13.3 Ligase
LIG3 7 17q11.2-q12 Ligase
MUTYH 7 1p34.1 Glycosylase
NEIL1 4 15q33.33 Glycosylase
NEIL2 43 8p23.1 Glycosylase
NTHL1 9 16p13.3 Endonuclease and Glycosylase
OGG1 7 3p26 Glycosylase
PARP1 18 1q41-q42 poly(ADP-ribosyl)ation
POLb 6 8p12-p11 Polymerase
POLD1 7 19q13.3 Polymerase
SMUG1 10 12q13.11–13.3 Glycosylase
XRCC1 21 19q13.2 Scaffolding protein
Genes are listed according to HUGO gene nomenclature format (http://www.genenames.org), Abbreviations: APEX1, APEX nuclease 1; FEN1, flap structure-specific
endonuclease 1; LIG1, ligase I, DNA, ATP-dependent; LIG3, ligase III, DNA, ATP-dependent; MUTYH, mutY homolog (E. coli); NEIL1, nei endonuclease VIII-like 1 (E. coli);
NEIL2, nei endonuclease VIII-like 2 (E. coli); NTHL1, nth endonuclease III-like 1 (E. coli); OGG1, 8-oxoguanine DNA glycosylase; PARP, poly (ADP-ribose) polymerase 1;
POLb, polymerase (DNA directed),beta; POLD1, polymerase (DNA directed), delta 1, catalytic subunit 125 kDa; SMUG1, single-strand-selective monofunctional uracil-
DNA glycosylase 1; XRCC1, X-ray repair complementing defective repair in Chinese hamster cells 1.
doi:10.1371/journal.pone.0071211.t001
BER Pathway and Colorectal Adenoma Risk
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Table 2. Demographics and descriptive characteristics of cases and controls.
Controls Cases
Variable n=736 % n=721 % p
Mean age at interview,y (6SD) 61.46 6.75 61.67 6.88 0.550
Mean Smoking years,y (6SD) 14.6 16.77 18.52 17.86 ,0.001
Mean smoking packyears, (6SD) 16.61 31.51 21.04 31.51 0.008
Mean alcohol intake, y (6SD) 8.03 14.76 9.44 18.54 0.108
Mean dietary folate, mcg/day (6SD) 366.63 210.28 340.08 194.28 0.013
Mean Calories (6SD) 2046.25 951.76 2081 924.43 0.473
Mean dietary fiber, g/day (6SD) 22.84 13.18 21.43 12.67 0.036
Mean saturated fat, g/day (6SD) 23.37 13.38 24.4 13.42 0.147
Mean BMI (6SD) 27.08 4.79 27.57 4.61 0.051
Median Age at interview,y
#60 yrs 331 44.97 313 43.41 0.549
.60 yrs 405 55.03 408 56.59
Race/ethnicity
non-Hispanic White 386 52.59 372 52.10 0.344
African-American 112 15.26 126 17.65
Hispanic 149 20.30 123 17.23
Asian-Pacific Islander 79 10.76 80 11.20
Other 8 1.09 13 1.82
Sex
Male 479 65.17 465 64.49 0.787
Female 256 34.83 256 35.51
Clinic of diagnosis
Bellflower 472 64.13 464 64.36 0.929
Sunset 264 35.87 257 35.64
Study Phase
Phase I 460 62.50 438 60.75 0.492
Phase II 276 37.50 283 39.25
Number of Adenomas
1 638 88.73
$2 81 11.27
Missing 2
Adenoma site
Rectum (,15 cm) 137 19.13
Colon ($15 cm) 579 80.87
Missing 5
Adenoma size
Small (,1 cm) 476 66.85
Large ($1 cm) 236 33.15
Missing 9
Smoking
Never 301 42.94 253 36.77 ,0.001
Former 326 46.50 312 45.35
Current 74 10.56 123 17.88
Missing 35 33
Smoking years
Never 301 43.43 253 37.21 ,0.001
.0–26 yrs 198 28.57 168 24.71
.26 yrs 194 27.99 259 38.09
Missing 43 41
BER Pathway and Colorectal Adenoma Risk
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BER Genes and Adenoma Risk Taking into Account
Adenoma Size and Location
We did not find evidence of any statistically significant per-allele
associations within either the small polyp (,1 cm) or large polyp
($1 cm) group after multiple comparisons adjustment within gene
region (PACT). When adenomas location (colon versus rectum), we
observed two NEIL2 tagSNPs were associated with increased risk
for rectal adenomas: NEIL2 rs7015453 (OR=1.72;
95%CI= 1.24–2.39; PACT= 0.025; pheterogeneity = 0.003) and
rs3757949 (OR=1.58; 95%CI= 1.18–2.13; PACT=0.044;
pheterogeneity = 0.004) (Table 4). These two tagSNPs were not
found to be in LD among NHW (r2 = 0.11), among whom we
observed similar findings (data not shown). Complete data for
analysis by adenoma location can be found in Table S3.
Genetic Variation in BER Genes, Adenoma Risk and
Alcohol
Statistically significant interactions were observed for LIG3
rs1052536 and amount (0 g/day, #6 g/day, .6 g/day; interac-
tion pgene = 0.019, interaction ppathway=0.241) and frequency of
alcohol intake (never, 1 drink/day, .1 drink/day; interaction
pgene = 0.029, interaction ppathway =0.345) (Table 5). Specifically,
among carriers of two major (C) alleles, those who drank more
than one drink per day had an 84% increased risk of adenoma
compared with non-drinkers (OR=1.84; 95%CI=1.09–3.11;
p = 0.022; p for trend = 0.024), and those who drank more than 6
grams per day had a 77% increased risk of adenoma compared
with non-drinkers (OR=1.77; 95%CI= 1.17–2.68; p= 0.006;
p for trend = 0.003). There was no association between alcohol
and adenoma risk for subjects with 1 minor (T) allele (Table 5).
When restricting analyses to NHW we observed interactions for
LIG3 rs1052536 that were of similar magnitude although not
statistically significant (data not shown).
Genetic Variation in BER Genes, Adenoma Risk and
Dietary Folate Intake
We observed that the association between folate and adenoma
risk was modified by two LIG3 tagSNPs (rs1052536 interaction
pgene=0.006, interaction ppathway =0.081; rs3744358 interaction
pgene = 0.032, interaction ppathway=0.451) (Table 5). For each of
Table 2. Cont.
Controls Cases
Variable n=736 % n=721 % p
Smoking Pack-years
Never 301 43.56 253 37.26 0.001
.0–21 196 28.36 171 25.18
.21 194 28.08 255 37.56
Alcohol intake
Never 283 38.45 268 37.33 0.323
#6 g/day 227 30.84 204 27.41
.6 g/day 226 30.71 246 34.26
Missing 0 3
Alcohol intake
Never 283 38.45 268 37.33 0.864
#15 g/day 333 45.24 327 45.54
.15 g/day230 g/day 50 6.79 46 6.41
.30 g/day 70 9.51 77 10.72
Missing 0 3
Alcohol intake
Never 283 38.45 268 37.33 0.871
#15 g/day 333 45.24 327 45.54
.15 g/day 120 16.30 123 17.13
Missing 0 3
Dietary folate
Low (#267 mcg/day) 248 33.70 283 40.60 0.024
Medium (.267–387 mcg/day) 241 32.74 210 30.13
High ($388 mcg/day) 247 33.56 204 29.27
Missing
Multivitamin use
No 303 41.28 293 42.40 0.668
Yes 431 58.72 398 57.60
Missing 2 30
doi:10.1371/journal.pone.0071211.t002
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Table 4. Significant BER per-allele associations by polyp sub-site.
Rectal Polyp Colon Polyp Rectal/Colon
Gene SNP CA/COa ORb 95%CI Pc PACT
d P pathway
e CA/COa ORb 95%CI Pc PACT
d P pathway
e phet
f
NEIL2 rs3757949 123/669 1.58 1.18–2.13 0.002 0.044 0.610 528/669 1.02 0.85–1.23 0.795 1.000 1.000 0.004
NEIL2 rs7015453 123/670 1.72 1.24–2.39 0.001 0.025 0.346 525/670 1.03 0.84–1.27 0.738 1.000 1.000 0.003
aExcludes 21 individuals who characterized their race/ethnic group as "other.";
bPer-allele ORs and 95%confidence intervals computed using multinomial logistic regression assuming a log-additive model and adjusting for age, exam date, sex,
clinic, study phase, and race among all study participants;
cCrude p-value;
dCrude p-value corrected for multiple comparisons using PACT;
ePathway wide (ppathway) p-value based on Bonferroni correction of PACT for the number of BER gene regions investigated (N = 14);
fp-value for heterogeneity by polyp subsite.
doi:10.1371/journal.pone.0071211.t004
Table 3. Colorectal adenoma SNP associations among the entire population and stratified by race/ethnicity.
Gene SNP All combined Non-Hispanic White African-American Hispanic Asian-Pacific Islander Phet
e
NEIL2 rs11785481 0.131
Ca/Coa 666/692 354/364 121/109 116/140 75/79
OR b 0.70 0.64 0.60 1.29 0.25
95%CI 0.55–0.90 0.48–0.87 0.24–1.53 0.72–2.31 0.05–1.37
pc 0.006 0.004 0.286 0.387 0.111
pACT
d 0.139 0.089 1.000 1.000 0.806
FEN1 rs108499 0.024
Ca/Coa 691/663 353/365 122/109 113/140 75/77
OR b 1.06 0.95 0.67 1.09 2.12
95%CI 0.90–1.25 0.76–1.18 0.37–1.21 0.76–1.57 1.30–3.45
pc 0.516 0.635 0.185 0.641 0.002
pACT
d 1.000 1.000 0.645 1.000 0.009
APEX1 rs17111750 0.004
Ca/Coa 695/664 354/367 121/110 114/140 75/78
OR b 1.00 0.88 2.19 0.78 1.04
95%CI 0.85–1.18 0.71–1.10 1.36–3.55 0.52–1.15 0.58–1.86
pc 0.981 0.271 0.001 0.208 0.897
pACT
d 1.000 0.781 0.013 0.573 1.000
FEN1 rs509360 697/665 0.052
Ca/Coa 697/665 353/367 122/111 116/140 74/79
OR b 0.93 0.95 1.27 1.09 0.49
95%CI 0.78–1.09 0.76–1.19 0.81–2.01 0.71–1.68 0.30–0.79
pc 0.358 0.662 0.302 0.694 0.003
pACT
d 0.888 1.000 0.746 1.000 0.011
NTHL1 rs2516781 0.062
Ca/Coa 688/664 353/363 122/108 115/140 74/77
OR b 0.91 1.01 0.83 1.06 0.45
95%CI 0.77–1.08 0.80–1.27 0.51–1.34 0.74–1.52 0.25–0.80
pc 0.271 0.960 0.445 0.747 0.006
pACT
d 0.840 1.000 0.960 1.000 0.033
aExcludes 21 individuals who characterized their race/ethnic group as "other";
bPer-allele ORs and 95%confidence intervals computed using logistic regression assuming a log-additive model and adjusting for age, exam date, sex, clinic, study
phase and race among all study participants;
cCrude p-value;
dCrude p-value corrected for multiple comparisons using PACT;
eRace/ethnicity specific per-allele ORs and 95% confidence intervals computed using logistic regression assuming a log-additive model and adjusting for the matching
factors age, exam date, sex, clinic, study phase; e p-value for heterogeneity by race.
doi:10.1371/journal.pone.0071211.t003
BER Pathway and Colorectal Adenoma Risk
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the two LIG3 tagSNPs, among individuals with one copy of the
minor allele, those with the highest level of dietary folate intake
had a 31% and 37% decreased adenoma risk compared to those
with the lowest level of dietary folate intake for LIG3 rs1052536
(OR=0.61; 95%CI= 0.51–0.93; p = 0.015; p for trend = 0.021) and
LIG3 rs3744358 (OR=0.63; 95%CI= 0.45–0.90; p = 0.010;
p for trend=0.003), respectively. Among individuals with two copies
of the minor allele, those with the highest level of dietary folate
intake had a 72% and 73% decreased adenoma risk compared to
those with the lowest level of dietary folate intake for LIG3
rs1052536 (OR=0.37; 95%CI= 0.20–0.65; p = 0.0007) and LIG3
rs3744358 (OR=0.38; 95%CI= 0.19–0.75; p= 0.006), respec-
tively. Among individuals with 2 copies of the major alleles there
was no statistically significant trend across increasing levels of
dietary folate intake. When restricting analyses to NHW, similar
statistically significant trends were observed for rs1052536 and
rs3744358 (data not shown). There is no evidence of LD between
LIG3 tagSNPs rs3744358 and rs1052536 among NHW.
Genetic Variation in BER Genes, Adenoma Risk and
Smoking
No statistically significant interactions were observed when we
considered smoking status (never/quit/current) or smoking
duration, after applying within gene Bonferroni corrections.
However, we observed that SNPs in three genes modified the
association between smoking pack-years and adenoma risk, with
statistically significant interaction tests that survived within gene
Bonferroni correction. First, we observed smoking pack-years was
modified by MUTYH rs10890324 (interaction pgene=0.007,
interaction ppathway=0.091) (Table 5). Whereas among individuals
with two copies of the major (A) allele there was no association
between increasing pack-years and adenoma risk
(p for trend = 0.871), among carriers of one copy of the minor (G)
allele, having smoked over 21 pack-years was associated with a
76% increased adenoma risk when compared to never smokers
(OR=1.76; 95%CI=1.29–2.42; p,0.001; p for trend ,0.001).
Among carriers of two minor (G) alleles, smoking more than 21
pack-years was associated with a 3-fold increased risk of adenomas
(p for trend ,0.001). Analysis among non-Hispanic Whites was not
performed due to sparse data.
Second, the OGG1 rs159153 SNP modified the association
between smoking pack-years and adenoma risk (interaction
pgene=0.040, interaction ppathway =0.517). While among
individuals with two copies of the major (A) allele there was no
association between increasing pack-years and adenoma risk
(p for trend = 0.610), among carriers of one copy of the minor (C)
allele, having smoked over 21 pack-years was associated with a
75% increased adenoma risk when compared to never smokers
(OR=1.75; 95%CI= 1.26–2.44; p= 0.001; p for trend ,0.001).
Among individuals carrying a second minor (C) allele, smoking
over 21 pack-years was significantly associated with an almost 3-
fold increased risk of adenoma (p for trend ,0.001) when compared
to never smokers. Significant trends of increasing adenoma risk
among carriers of 1 and 2 minor alleles were observed with
increasing smoking years, but there was no statistically significant
evidence of interaction between OGG1 rs159153 and smoking
years and adenoma risk.
Finally, the FEN1 rs108499 SNP also modified the association
between smoking pack-years and adenoma risk (interaction
pgene=0.039, interaction ppathway=0.507). Among individuals with
two copies of the major (C) allele smoking more than 21 pack-
years was associated with a 2-fold increased risk of adenomas
compared to never smokers (p for trend ,0.001) but there was no
association among individuals with either one copy of the minor
(T) allele or two copies of the minor (T) allele (Table 5). While a
similar significant trend of increasing adenoma risk was observed
with increasing smoking years, there was no statistically significant
evidence of interaction. Analyses among NHW only were not
performed due to sparse data.
Discussion
We investigated potential associations between 182 tagSNPs
from 14 BER gene regions and their role in modifying the effects
of smoking, dietary folate intake and alcohol consumption on
colorectal adenoma risk. We observed statistically significant
associations between colorectal adenoma risk and polymorphisms
in the FEN1 gene (two tagSNPs) and NTHL1 gene (one tagSNP)
Table 5. Cont.
Exposure variable CA/CO CA/CO CA/CO OR a,b,c 95%CI P OR a,b,c 95%CI P OR a,b,c 95%CI P
FEN1 rs108499
Smoking Pack-yrs CC CT TT C/C C/T T/T
Never 95/118 87/108 48/44 1ref 1ref 1ref
.0–21 64/70 56/86 32/27 1.02 0.67–1.54 0.926 0.96 0.71–1.29 0.771 0.90 0.52–1.56 0.7
.21 124/79 82/78 21/22 1.99 1.36–2.91 ,0.001 1.25 0.92–1.71 0.156 0.79 0.44–1.41 0.424
p trend ,0.001 0.102 0.446
interaction pd=0.013; interaction pgene
e = 0.039; interaction ppathway
f = 0.507
aOdds ratios (ORs) are from models with genotype coded as log-additive (treated as continuous) and adjusted for age, sex, clinic, exam date, study phase, and race
among all study participants. Excludes 21 individuals who characterized their race/ethnic group as "other";
bORs for smoking additionally adjusted for alcohol intake (g/d) and dietary folate intake (mcg/day); ORs for alcohol additionally adjusted for smoking pack-years and
dietary folate intake (mcg/d); ORs for dietary folate intake, additionally adjusted for alcohol intake (g/d) and smoking pack-years;
cORs derived from a common baseline model that included the SNP, smoking, alcohol, dietary folate exposure and interaction terms between genotype and smoking,
alcohol, dietary folate exposure levels;
dCrude interaction p-value;
eWithin gene region, Bonferroni adjusted interaction p-value, based on the number of SNPs within the respective gene region;
fPathway wide, Bonferroni adjusted interaction p-value, based on 14 investigated BER gene regions.
doi:10.1371/journal.pone.0071211.t005
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among Asian-Pacific Islanders, and the APEX1 gene among
African-Americans (one tagSNP). Significant associations were
also observed for two unlinked tagSNPs in the NEIL2 gene and
rectal adenoma risk. None of the six tagSNPs were found to
modify the effects of dietary folate, or alcohol on adenoma risk.
However, one of these six tagSNPs, FEN1 rs108499, was found to
modify the effects of smoking on adenoma risk. Moreover, we
observed evidence that SNPs in other BER genes modified the
effect of smoking (MUTYH, OGG1), alcohol (LIG3), and dietary
folate (LIG3) on colorectal adenoma risk. Overall, our findings
support the hypothesis that oxidative damage induced by these
exposures may play an important role in colorectal adenoma
development.
Previous studies have investigated BER gene polymorphisms
and adenoma risk [25,26,34,35,36,37,38]. With one exception
[38], they have been limited to a handful of candidate SNPs within
XRCC1, PARP1, OGG1, and APEX genes. Even fewer considered
the modifier role of alcohol, smoking or dietary folate intake
[26,37,38]. Therefore, to our knowledge, this is the first
comprehensive examination of the BER pathway and colorectal
adenoma risk taking into account relevant environmental risk
factors.
We report a two-fold increased adenoma risk associated with
SNP rs17111750 located 59-upstream of APEX1, only among
African-Americans. The human APEX1 protein is an apurinic/
apyrimidinic endonuclease that repairs DNA damage caused by
oxidative and alkylating agents [39]. A previous study has reported
a positive association between this SNP and colorectal adenoma,
and another one reported lack of association with prostate cancer
risk [38,40]. Among African-Americans APEX1 rs17111750 is not
in LD (r2,0.05) with two other APEX1 SNPs, rs1048945 and
rs1130409, previously reported by us and others to be associated
with CRC and adenoma risk [37,41,42,43].
We observed that the minor alleles of the FEN1 SNPs rs509360
and rs108499 were associated with a two-fold increased and
decreased risk of adenoma, respectively, among Asian-Pacific
Islanders. Moreover, among all subjects combined, rs108499 was
found to modify the effect of smoking on adenoma risk. Both
rs509360 and rs108499 are located 59-upstream of FEN1,
occurring within intronic regions of C11orf9. A previous study
among predominantly NHW found no associations between these
FEN1 SNPs and colorectal adenoma [38]. The FEN1 endonucle-
ase is involved in BER and DNA replication and has been
reported to play important roles in genomic stability [44], chronic
inflammation, autoimmunity and cancers [45,46]. In two studies
conducted among Chinese populations, polymorphisms in the
FEN1 promoter and 39-UTR were associated with reduced FEN1
expression, increased DNA damage and increased risks for lung
and CRC [47,48].
The NTHL1 rs2516781 SNP was associated with a two-fold
decreased risk of adenoma only among Asian-Pacific Islanders.
The NTHL1 protein has DNA N-glycosylase activity as well as
apurinic and/or apyrimidinic endonuclease activity [49,50,51].
The rs2516781 SNP is 39-downstream of the NTHL1 gene, an
intronic SNP within the solute carrier family 9 (sodium/hydrogen
exchanger), member 3 regulator 2 (SLC9A3R2) gene. SLC9A3R2 is
involved in regulation of SLC9A3, the sodium/hydrogen ex-
changer involved in intestinal sodium absorption [52]. This SNP
has not been previously assessed in studies of colorectal adenoma
or CRC.
Two NEIL2 SNPs, rs11785481 and rs3757949, were associated
with risk for rectal adenomas. Among NHW these two SNPs are
not in LD (r2,0.1). The NEIL2 protein has DNA glycosylase
activity and apurinic/apyrimidinic endonuclease activity [39]. The
rs3757949 SNP, is an intronic SNP located within GATA4, a gene
that codes for a transcription factor relevant for gene expression in
gastrointestinal epithelium [53,54]. Promoter hyper-methylation
and the subsequent transcriptional silencing of GATA4 are
commonly seen in CRC cell lines and primary CRCs [55].
We found evidence that the MUTYH rs10890324 SNP, which
flanks the 39-end of MUTYH, modified the association between
smoking and adenoma risk. The MUTYH gene encodes a DNA
glycosylase, and germline mutations in highly conserved residues of
the MUTYH gene predispose individuals to MUTYH-associated
polyposis coli [56] as well as sporadic CRC [57,58]. We also found
that theOGG1 rs159153 SNP, located 59-upstream of OGG1, modified
the association between smoking and adenoma risk. The 8-
oxoguanine glycosylase 1 (OGG1) enzyme can excise the highly
mutagenic 8-oxoguanine lesions induced by ROS and normal cellular
metabolism [59]. The more commonly investigated OGG1 Ser326Cys
SNP (rs1052133) is not in LD with rs159153 among NHW (r2=0.08).
Finally, we found evidence that the LIG3 rs1052536 SNP
modified the association between alcohol intake and adenoma risk.
In addition, LIG3 SNPs rs1052536 and rs3744358 modified the
association between dietary folate intake and adenoma risk. LIG3,
a ligase involved in maintaining genomic integrity, encodes
proteins present in the mitochondria and nucleus.
Our study had several strengths, including the relatively large
sample size and the use of a comprehensive tagSNP approach to
thoroughly investigate genetic variation in 14 BER genes. Among
the weaknesses of our study is the fact that results are only
applicable to the sigmoid colon and rectum, and the fact that cases
had colonoscopy performed but not controls; therefore, some
controls might have had more proximal polyps out of reach of
sigmoidscope [60]. Even though we conducted a large number of
tests as part of our analyses, we believe our approach for multiple
comparisons adjustment in the SNP main effect analyses and the
gene environment analyses is a conservative method of reducing
the number of false positive results.
In conclusion, our findings suggest that genetic variation in non-
coding BER gene regions can modify the risk of adenoma,
particularly in combination with key environmental exposures.
These findings highlight a relevant role for oxidative damage
induced by these environmental exposures in colorectal adenoma
development.
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